BioSpace News Archive

Kashiv Biosciences, LLC (“Kashiv” or the “Company”) is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved its Biologics License Application (“BLA”) for pegfilgrastim-pbbk, a biosimilar referencing Neulasta®.

According to Vision Research Reports, the global biopsy guidance system market size is expected to be worth around US$ 1,883.5 Million by 2030 and is predicted to grow at a CAGR of 5.9% during forecast period 2021 to 2030.

According to Vision Research Reports, the global Healthcare ERP Market size is expected to worth around US$ 15.3 billion by 2030 and is projected to grow at a CAGR of 8.6% during forecast period 2021 to 2030.

Veracyte, Inc. (Nasdaq: VCYT) announced today that new data published online in The Lancet Oncology suggest that the company’s Immunoscore Immune Checkpoint (IC) assay may identify patients with metastatic colorectal cancer (mCRC) who are likely to benefit from the addition of immune checkpoint inhibitor (ICI) therapy to standard first-line treatment.

Aruna Bio, Inc. announced that it has received funding from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health of Health to advance AB126™, a multimodal neuroprotective and regenerative neural stem cell extracellular vesicle product, to treat Traumatic Brain Injury.

Alpha Cognition Inc. announces the grant of stock options pursuant to its stock option plan to certain directors of the Company to purchase up to an aggregate of 400,000 common shares of the Company.

Innovent Biologics, Inc. announced the appointment of Mr. Gary Zieziula as an independent non-executive director of the board of directors and a member of the audit committee of the Board and the strategy committee of the Board.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2022, to be held in Charlotte, North Carolina from June 4-8, 2022.

Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director.

Medline announced skin health and wound care workshops in 2022 to help drive standardization of care and empower frontline caregivers across the continuum of care.